Trials / Conditions / Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma
Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma
3 registered clinical trials studyying Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular L NCT01829568 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-C NCT01193842 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Fol NCT01145495 | National Cancer Institute (NCI) | Phase 2 |